Nom du produit:2-((5-(4-Chlorophenyl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)-N-cyclohexylacetamide

IUPAC Name:2-{[5-(4-chlorophenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}-N-cyclohexylacetamide

CAS:309266-55-5
Formule moléculaire:C22H23ClN4OS
Pureté:98%
Numéro de catalogue:CM1072075
Poids moléculaire:426.96

Unité d'emballage Stock disponible Prix($) Quantité
CM1072075-100mg in stock ǎţƴ
CM1072075-250mg in stock ijŽř
CM1072075-1g in stock řǟţǎ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:309266-55-5
Formule moléculaire:C22H23ClN4OS
Point de fusion:-
Code SMILES:O=C(CSC1=NN=C(C2=CC=C(Cl)C=C2)N1C3=CC=CC=C3)NC4CCCCC4
Densité:
Numéro de catalogue:CM1072075
Poids moléculaire:426.96
Point d'ébullition:
N° Mdl:
Stockage:Sealed in dry,2-8°C.

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.